The administrations of various carcinogens to young mice before puberty induce hepatocellular tumourigenesis, male mice being more susceptible to these carcinogens than females (Klein, 1959 ; Klein & Weisburger, 1966; Vesselinovitch & Mihailovich, 1967; Vesselinovitch, 1969; Roe et al., 1971; Vesselinovitch et al., 1972; 1974; Rao & Vesselinovitch, 1973; Moore et al., 1981; Yamamoto et al., 1991) . This sex difference in susceptibility is partly ascribable to the promoting effect of testosterone secreted by the testes after puberty (Vesselinovitch et al., 1980; Moore et al., 1981; Kemp et al., 1989; Weghorst & Klaunig, 1989) . The promoting effect of testosterone on hepatocellular tumourigenesis has been studied not only in mice but also in rats, and has been shown to be due to indirect actions of testosterone on tissues other than the liver, such as the thyroid gland, not to a direct action on the liver (Toh, 1973; Kemp et al., 1989) . On the other hand, several studies (Vesselinovitch & Mihailovich, 1967; Vesselinovitch et al., 1980; Goldfarb & Pugh, 1990; Yamamoto et al., 1991) have indicated that the ovaries suppress hepatocellular tumourigenesis in mice, ovariectomy after the administration of carcinogens shortening the latency in development of hepatocellular tumours and increasing the incidence of tumours. These studies suggest that the ovarian hormones, estrogen and progesterone, suppress hepatocellular tumourigenesis. As far as we know, however, the suppressive effects of these two hormones on hepatocellular tumourigenesis in mice have not been studied.
The administration of 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB) to neonatal female mice induces hepatocellular tumourigenesis (Roe et al., 1971; Yamamoto et al., 1991) and ovariectomy at 1 month of age hastens the development of hepatocellular tumours (Yamamoto et al., 1991) . In the present study, we investigated the effects of estradiol-17P and progesterone on the development of hepatocellular tumours induced-by 3'-Me-DAB. We also examined whether the suppressive actions of these hormones are due to direct actions on the liver or indirect actions on tissues other than the liver.
Materials and methods

Mice
Female C57BL/6 x DS-F1 mice bred in our laboratory were used. These mice were kept at 25°C under controlled lighting (12 h light/12 h darkness) and allowed free access to water and pellet food. Mice were ovariectomised under pentobarbital sodium anaesthesia.
Administration of carcinogen 3'-Me-DAB (ICN Pharmaceuticals, Plainview, NY, USA) was suspended in an aqueous solution of 0.7% (w/v) gelatin at a concentration of 10 mg ml-', and 0.05 ml of the suspension was injected i.p. into mice of 10, 12, 14, 16 and 18 days old.
Implantations of estradiol-17I and progesterone Cylindrical cholesterol pellets containing 1% (w/w) estradiol-17P (E2), hereafter called E2 pellets, were prepared, and an E2 pellet of 10 or 5 mg was implanted s.c. into the interscapular space or the spleen. E2 pellets implanted s.c. were changed every 4 months, but those implanted into the spleen were not. Progesterone (about 12.5 mg) was introduced into a silastic tube (1 cm length), and four silastic tubes were implanted s.c. into the interscapular space. These silastic tubes were changed every 3 months. Doses of E2 and progesterone were determined based on the results of a preliminary experiment in which the effects of these steroids on the uterine weight were examined. (12-15 sections/the liver) were examined for adenomatous nodules. An adenomatous nodule of hepatocellular origin in the liver was defined with reference to previous reports (Vesselinovitch et al., 1978; Frith et al., 1980; Lipsky et al., 1981a) as described previously (Yamamoto et al., 1991) as a mixture of eosinophilic, basophilic, vacuolated and foamy hepatocyte in various proportions that compressed the adjacent parenchyma, but did not contain a carcinomatous lesion with a trabecular structure. Number of adenomatous nodules ranged from one to three per the liver.
Histochemical examination ofglucose-6-phosphatase The right lobe of the liver was removed, and promptly frozen in liquid nitrogen. A frozen section of the widest area was cut at in 5-6pjm thickness on a cryostat and stained for glucose-6-phosphatase (G-6-Pase) by the method of Wachstein and Meisel (1957) and examined for G-6-Pase deficient foci. All adenomatous nodules were G-6-Pase deficient. Thus, G-6-Pase deficient foci ( Figure 1 ) include both preneoplastic lesions and adenomatous nodules (Moore et al., 1981; Lipsky et al., 1981b; Hacker et al., 1991) . Number of G-6-Pase deficient foci ranged from one to six per a section of the widest area of the right lobe of the liver.
Labelling index For examination of the labelling indices of adenomatous nodules, mice were given an i.p. injection of [methyl-3H] thymidine (2 ltCi g-' body wt; 86.4 Ci mmol 1; New England Nuclear Corp., Boston, MA, USA), and were killed 4 h later.
After fixation in Zamboni's solution, the liver was cut into 4 mm thick serial strips. Autoradiography of a thin section of each strip was carried out by exposure for 21 days as described previously (Terada et al., 1989 Figure 2 shows the effect of ovariectomy of 1-month-old female mice treated with 3Y-Me-DAB neonatally on the incidences of hepatocellular adenomatous nodules and G-6-Pase deficient foci. Adenomatous nodules and G-6-Pase deficient foci were first found in the liver of 16-and 12-month-old intact females, respectively. However, in the liver of ovariectomised females, adenomatous nodules and G-6-Pase deficient foci were first found at 8 and 6 months of age, respectively, and their incidences increased gradually thereafter. The incidences of adenomatous nodules and G-6-Pase deficient foci in ovariectomised females were significantly higher than those in intact females of the same age. Carcinoma was found only in one of 14 ovariectomised females at 16 months of age, and not in intact females of the Figure 3 shows the effects of oestrogen and progesterone on the incidences of adenomatous nodules and G-6-Pase deficient foci in ovariectomised females at 10 or 12 months of age. Ovariectomy at 1 month of age resulted in marked increases in the incidences of adenomatous nodules and G-6-Pase deficient foci at 10 or 12 months of age, and s.c. implantation of E2 pellets (10 mg) markedly decreased their incidences. On the other hand, s.c. implantation of four silastic tubes, each containing about 12.5 mg of progesterone did not decrease the incidences of adenomatous nodules and G-6-Pase deficient foci at 10 months of age, while s.c. implantation of both E2 pellets and four silastic tubes containing progesterone reduced their incidences to the levels in the group with implantation of E2 pellets only. Figure 4 shows the effects of oestrogen and progesterone on uterine weight. The uterine weight of ovariectomised females with implanted progesterone was significantly more than that of ovariectomised females without an implant, and implantation of progesterone plus E2 pellets significantly decreased the uterine weight relative to that on implantation of E2 pellets only.
The labelling indices (means ± SE) of adenomatous nodules of 3-5 mm diameter in intact females, females ovariectomised at 1 month of age, and females ovariectomised at 1 month of age with E2 pellets implanted s.c. at 12 months of age were 1.24 ± 0.22% (n = 5), 3.10 ± 0.10% (n = 9), and 1.01 + 0. 14% (n = 6), respectively, at 15 months of age. The labelling index of adenomatous nodules in ovariectomised females was significantly (P <0.05) higher than that in intact females, and was reduced significantly (P <0.05) by implantation of E2 pellets for 3 months. Figure 5 shows the effects of s.c. and intrasplenic implantations of E2 pellets at 6 months of age on the incidences of adenomatous nodules and G-6-Pase deficient foci at 10 months of age. The s.c. implantation of an E2 pellet (10 mg) significantly reduced the incidences of both adenomatous nodules and G-6-Pase deficient foci, but the intrasplenic implantation of an E2 pellet (10 or 5 mg) did not. The uterine weight of ovariectomised females with E2 pellets implanted s.c. was comparable to that of females without ovariectomy (intact females), whereas the uterine weight of ovariectomised females with an E2 pellet implanted into the spleen was as low as that of ovariectomised females without an implant ( Figure 6 ). In the experiment shown in Figure 5 , mice received the intrasplenic implantation of E2 pellets were excluded from the experiment when adhesion of the spleen to the abdominal wall was found at sacrifice. The uterine weight of these mice with intrasplenic E2 pellets (10 mg) was 116.8 ± 23.0 mg (mean ± SE for eight mice), ranging from 43.2 to 238.3 mg).
Discussion
Carcinogen-induced preneoplastic and neoplastic lesions in rat and mice show alterations in activities of various enzymes including G-6-Pase activity (Bannasch, 1986) . Hacker et al. (1991) reported that diethylnitrosamine-induced preneoplastic lesions in mice were G-6-Pase deficient, but adenomas showed increased or decreased G-6-Pase activity and carcinomas showed increased G-6-Pase activity. On Figure 5 Effects of estradiol-1 7p implanted s.c. or into the spleen on the incidences of adenomatous nodules and G-6-Pase-deficient foci. Female mice were treated with 3'-Me-DAB neonatally. These females were ovariectomised at I month of age. At 6 months of age ovariectomised females received a E2 pellet (10 mg) s.c. or a E2 pellet (10 or 5 mg) in the spleen. All mice were killed at 10 months of age. Numbers above columns indicate numbers of mice examined. 'Significant difference from the value for females ovariectomised at 1 month of age without implantation by the Chi-square test (P<0.05). (Metzler & Degen, 1987 (Samuel & Eik-Nes, 1968 1981b; 1989) reported that safrole-induced or in these mice, a part of E2 secreted from E2 pellets enters the eldrin and DDT-induced preneoplastic lesions, adenomas systemic circulation through veins of the abdominal wall. id carcinomas were all G-6-Pase deficient. In the present
The uterine weights of some of these mice with E2 pellets udy, adenomatous nodules were G--Pase deficient, and (10 mg) were comparable to those of mice which had received ere included in G-6-Pase deficient lesions. However, since the s.c. implantation with E2 pellets, suggesting that intras--6-Pase deficient lesions appeared earlier than adenomatous plenic E2 pellets could secrete E2 as long as s.c. E2 pellets.
idules both in intact and ovariectomised females treated Thus, it is unlikely that no suppressive effects of the intrasith 3'-Me-DAB neonatally, G-6-Pase deficient lesions except plenic implantation of E2 pellets is ascribed to the rapid lenomatous nodules seem to be preneoplastic lesions as absorption of E2 from a pellet. Rather, the present results ggested in hepatocellular tumourigenesis induced by the suggest that E2 suppresses hepatocellular tumourigenesis in her carcinogens (Frith et al., 1980; Lipsky et al., 1981a;  mice by its actions on tissue other than the liver. Since 81b; 1989; Moore et al., 1981; Vesselinovitch & oestrogen modulates the secretion of pituitary hormones, ihailovich, 1983). Our previous study (Yamamoto et al., especially prolactin (Toh, 1973; Meites, 1974) , the pituitary 91) using both female and male mice treated with 3'-Megland may be involved in the suppressive effects of oestrogen AB neonatally, showed that adenomatous nodules on hepatocellular tumourigenesis. On the other hand, Goldpeared earlier than carcinomas in males, and that the farb and Pugh (1990) have suggested that the promoting arked decrease in incidence of adenomatous nodules in effect of ovariectomy on hepatocellular tumourigenesis in males was accompanied by the marked decrease in mice may be related to weight gain, as ovariectomy results in cidence of carcinomas. Thus, it is also likely that carweight gain and as obesity, either strain specific or induced nomas may arise from adenomatous nodules.
by gold thioglucose, is associated with a shortening of the E2 suppressed the development of both adenomatous latency in liver tumour development in mice (Waxler & dules and G-6-Pase deficient foci. G-6-Pase deficient foci Tabar, 1953; Gray et al., 1960) . clude both preneoplastic lesions and adenomatous nodules
In this study we found that s.c. implantation of E2 loore et al., 1981; Lipsky et al., 1981a; 1981b;  decreased the incidences of adenomatous nodules and G-6-acker et al., 1991). Thus, this result indicates that E2 supPase deficient foci, but that s.c. implantation of progesterone esses the formation of preneoplastic lesions from initiated did not. However, progesterone implanted s.c. significantly patocytes, as well as the progression of preneoplastic increased the uterine weight of ovariectomised mice and ions into adenomatous nodules. Furthermore, as E2 inhibited the increase in uterine weight induced by E2, creased the labelling index of adenomatous nodules, it also indicating that when implanted s.c., it was an effective source :ms to suppress growth of adenomatous nodules. These of progesterone (Terada et al., 1989) . Thus, it is likely that sults are consistent with a report by Goldfarb and Pugh progesterone does not affect hepatocellular tumourigenesis, N90) that ovariectomy accelerated the growth of hepatocel-and that only oestrogen secreted by the ovaries is responsible lar neoplasms of mice induced by diethylnitrosamine.
for the suppressive effect of the ovaries on hepatocellular Although there are no reports on the effects of E2, the tumourigenesis in mice.
Dst potent natural oestrogen, on hepatocellular
We conclude from the present results that ovarian oestmourigenesis in mice, there are several reports on the rogen suppresses hepatocellular tumourigenesis by actions oñ ects of synthetic oestrogens on hepatocellular tissues other than the liver. tumourigenesis in mice and rats. Studies on the effects of synthetic oestrogens on hepatocellular tumourigenesis in mice have, however, given discrepant results (Lee et al., 1989; Vesselinovitch & Mihailovich, 1982) . Lee et al. (1989) reported that ethynyl estradiol suppressed the development of 
